Drug price controls based on market based rate, which was cleared by the cabinet is challenged in the Supreme Court through a public interest litigation filed by All India Drug Action Network (AIDAN), reports CNBC-TV18‘s Rituparna Bhuyan.
first published: Nov 27, 2012 03:24 pm
A collection of the most-viewed Moneycontrol videos.
Nifty Headed For All-Time Highs After Friday’s Late Recovery?| Opening Bell Live
This Tenant Moved from a 100sqft Slum to a Premium Residence | The Tenant
Live: Nifty snaps 4-day winning streak but rises 1% this week | Closing Bell
Live: Can Bihar poll outcome trigger Nifty to reclaim 26,000-mark? | Opening Bell
